S46 - Child Neurology: Molecular Biology to Clinical Trials

Event Time: Thursday April 27, 2017 3:30 pm to 5:30 pm
Topic(s): Child Neurology and Developmental Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Microcephaly proteins Wdr62 and Aspm define a mother centriole complex regulating centriole biogenesis, apical complex and cell fate Divya Jayaraman
Dr. Jayaraman has nothing to disclose.

3:42 PM 002 Outcome following hemicraniectomy in children with acute stroke in the International Pediatric Stroke Study Laura Lehman, MD
Dr. Lehman has nothing to disclose.

3:54 PM 003 Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy Darryl C. De Vivo, MD, FAAN
Dr. De Vivo has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Biogen, Sarepta, PTC, Cytokinetics, Ultragenyx, and Sanofi. Dr. De Vivo has received research support from Sarepta, PTC, Ultragenyx, and Biogen, and also animal model licensing to Sanofi.

4:06 PM 004 Motor mapping by transcranial magnetic stimulation reveals a pathologically preserved immature motor lateralization in patients with intractable focal epilepsy Harper Kaye, Other
Dr. Harper has nothing to disclose.

4:18 PM 005 A Randomized Double-blind, Placebo-controlled, Cross-over Trial of Ganaxolone in Children and Adolescents with Fragile X Syndrome Julia Tsai
Dr. Tsai has received personal compensation for activities with Marinus. Dr. Tsai has received research support from Marinus.

4:30 PM 006 Long Term Outcomes and Risk Factors for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors Tejaswi Kandula
Dr. Kandula has nothing to disclose.

4:42 PM 007 Physician- and Patient-Reported Outcomes in X-linked Adrenoleukodystrophy: Accelerated Roadmap from Patients′ Insights to Clinical Trials Alexander Sherman
Dr. Sherman has nothing to disclose.

4:54 PM 008 PREPL deficiency: delineation of the phenotype and development of a functional blood assay Luc Regal
Dr. Regal has received personal compensation for activities with Genzyme and Shire.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses